Financhill
Back

Summit Therapeutics Vs. Crinetics Pharmaceuticals Industry Stock Comparison

Sell
46

SMMT
Summit Therapeutics

Last Price:
$17.96
Seasonality Move:
7.78%
Sell
2

CRNX
Crinetics Pharmaceuticals

Last Price:
$37.98
Seasonality Move:
-6.74%
Sell
46
Summit Therapeutics (SMMT) is a Sell

Is Summit Therapeutics a Buy, Sell or Hold?

  • The current Summit Therapeutics [SMMT] share price is $18.18. The Score for SMMT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • SMMT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
2
Crinetics Pharmaceuticals (CRNX) is a Sell

Is Crinetics Pharmaceuticals a Buy, Sell or Hold?

  • The current Crinetics Pharmaceuticals [CRNX] share price is $38.98. The Score for CRNX is 2, which is 96% below its historic median score of 50, and infers higher risk than normal.
  • CRNX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

SMMT Stock Price Chart

What is Summit Therapeutics's stock price today?

  • The Summit Therapeutics share price today is $18.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SMMT is experiencing buying pressure, which is a positive indicator for future bullish movement.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals's stock price today?

  • The Crinetics Pharmaceuticals share price today is $38.98
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRNX is experiencing slight selling pressure.

SMMT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.17 Sell
Relative Strength Index (14 RSI): 48.68 Sell
Chaikin Money Flow: 1356879 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.7 - 18.74) Sell
Bollinger Bands (100): (15.6 - 22.64) Sell

CRNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.13 Sell
Relative Strength Index (14 RSI): 21.13 Sell
Chaikin Money Flow: -690740 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (47.93 - 57.37) Sell
Bollinger Bands (100): (50.63 - 57.85) Sell

SMMT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.11 Buy
20-day SMA: 18.21 Sell
50-day SMA: 18.8 Sell
200-day SMA: 12.96 Buy
8-day EMA: 18.17 Buy
20-day EMA: 18.28 Sell
50-day EMA: 18.54 Sell
200-day EMA: 14.22 Buy

CRNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.98 Sell
20-day SMA: 51.29 Sell
50-day SMA: 54.96 Sell
200-day SMA: 50.99 Sell
8-day EMA: 46.42 Sell
20-day EMA: 50.33 Sell
50-day EMA: 53.11 Sell
200-day EMA: 49.76 Sell

Summit Therapeutics Earnings Growth & SMMT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and a decrease next year of $0.16 per share.

Crinetics Pharmaceuticals Earnings Growth & CRNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.47 per share.

Summit Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):